Globus Medical Buy Hold or Sell Recommendation

GMED -- USA Stock  

USD 51.84  0.49  0.95%

Given the investment horizon of 30 days, and your above average risk tolerance our recommendation regarding Globus Medical is 'Strong Buy'. Macroaxis provides Globus Medical buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding GMED positions. The advice algorithm takes into account all of Globus Medical available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from GMED buy-and-hold prospective. Please also check Globus Medical Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for muliple equity instruments please use Instant Ratings tool.

Time Horizon

Risk Tolerance

Symbol
Execute Advice
Sell Globus MedicalBuy Globus Medical
Strong Buy

Hype Condition

Current Valuation

Odds of Distress

Economic Sensitivity

Analyst Consensus

Piotroski F Score

Financial Leverage

Inapplicable
For the selected time horizon Globus Medical has a risk adjusted performance of 0.1786, jensen alpha of 0.3053, total risk alpha of 0.2799, sortino ratio of 0.2382 and treynor ratio of 0.6388
Macroaxis buy or sell recommendations tool can be used to complement Globus Medical buy, hold, or sell suggestion provided by experts. It analyzes the entity potential to grow against your specific risk preferences and investment horizon. To make sure Globus Medical is not overpriced, please check out all Globus Medical fundamentals including its Price to Earning, Net Income, Book Value Per Share, as well as the relationship between Revenue and Total Debt . Given that Globus Medical has Number of Shares Shorted of 2.59M, we strongly advise you confirm Globus Medical market performance and probability of bankruptcy to make sure the company can sustain itself in the current economic cycle given your regular risk tolerance and investing horizon.

Globus Medical Trading Alerts and Improvement Suggestions

Globus Medical current analysts recommendations

Target Median Price55.00
Target Mean Price53.55
Recommendation Mean2.40
Target High Price62.00
Number Of Analyst Opinions11
Target Low Price42.00

Globus Medical Returns Distribution Density

Mean Return0.32Value At Risk1.82
Potential Upside2.93Standard Deviation1.68
 Return Density 
      Distribution 

Institutional Investors

Security TypeSharesValue
Blackrock IncCommon Shares9.6 M407.3 M
Vanguard Group IncCommon Shares7.2 M303.8 M
Janus Henderson Group PlcCommon Shares6.2 M261.4 M
Wellington Management Group LlpCommon Shares4.4 M184.7 M
State Street CorpCommon Shares2.6 M111.3 M
Aqr Capital Management LlcCommon Shares2 M84.4 M
Van Berkom Associates IncCommon Shares1.5 M62.5 M

Globus Medical Greeks

α
Alpha over DOW
=0.31
β
Beta against DOW=0.49
σ
Overall volatility
=1.71
Ir
Information ratio =0.18

Globus Medical Volatility Alert

Globus Medical has relatively low volatility with skewness of 1.52 and kurtosis of 5.56. However, we advise all investors to independently investigate Globus Medical to ensure market all accessible information is consistent with the expectations about its upside potential and future risk-adjusted return.
    
 Better Than Average     
    
 Worse Than Average Compare Globus Medical to competition

Globus Medical Fundamental Vs Peers

FundamentalsGlobus MedicalPeer Average
Return On Equity12.02% (0.31)%
Return On Asset8.16% (0.14)%
Profit Margin19.30% (1.27)%
Operating Margin29.12% (5.51)%
Current Valuation4.83B16.62B
Shares Outstanding76.65M571.82M
Shares Owned by Insiders3.57% 10.09%
Shares Owned by Institutions92.44% 39.21%
Number of Shares Shorted2.59M4.71M
Price to Earning36.45X28.72X
Price to Book3.93X9.51X
Price to Sales6.81X11.42X
Revenue742.66M9.43B
Gross Profit553.56M27.38B
EBITDA216.23M3.9B
Net Income143.33M570.98M
Cash and Equivalents240.43M2.7B
Cash per Share2.43X5.01X
Total Debt1.98M5.32B
Debt to Equity0.10% 48.70%
Current Ratio6.94X2.16X
Book Value Per Share12.99X1.93K
Cash Flow from Operations32.12M971.22M
Short Ratio3.52X4.00X
Earnings Per Share1.40X3.12X
Price to Earnings To Growth2.87X4.89X
Number of Employees1.8K18.84K
Beta0.92-0.15
Market Capitalization5.06B19.03B
Total Asset834.1M29.47B
Retained Earnings524.56M9.33B
Working Capital462.11M1.48B
Current Asset544.8M9.34B
   Exercise or conversion by David Davidar of 25000 shares of Globus Medical subject to Rule 16b-3 [view details]
Search macroaxis.com